142 related articles for article (PubMed ID: 32030447)
1. Successful sirolimus treatment of patients with pure red cell aplasia complicated with renal insufficiency.
Chen Z; Liu X; Chen M; Yang C; Han B
Ann Hematol; 2020 Apr; 99(4):737-741. PubMed ID: 32030447
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus.
Long Z; Yu F; Du Y; Li H; Chen M; Zhuang J; Han B
Ann Hematol; 2018 Nov; 97(11):2047-2054. PubMed ID: 29982851
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group.
Sawada K; Hirokawa M; Fujishima N; Teramura M; Bessho M; Dan K; Tsurumi H; Nakao S; Urabe A; Omine M; Ozawa K;
Haematologica; 2007 Aug; 92(8):1021-8. PubMed ID: 17640861
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial.
Huang Y; Chen M; Yang C; Ruan J; Wang S; Han B
Leukemia; 2022 May; 36(5):1351-1360. PubMed ID: 35256763
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression therapy is effective for both acquired tumor-associated and primary pure red cell aplasia: a match pair case-control study.
Chen Z; Chen M; Yang C; Han B
Ann Hematol; 2020 Jul; 99(7):1485-1491. PubMed ID: 32488602
[TBL] [Abstract][Full Text] [Related]
6. Response to cyclosporine A and corticosteroids in adult patients with acquired pure red cell aplasia: serial experience at a single center.
Wu X; Wang S; Lu X; Shen W; Qiao C; Wu Y; Lu R; Wang S; Zhang J; Hong M; Zhu Y; Li J; He G
Int J Hematol; 2018 Aug; 108(2):123-129. PubMed ID: 29589280
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of Cyclosporine A and Cyclosporine A Combined with Corticosteroid in the Treatment of Acquired Pure Red Cell Aplasia].
Zhang RX; Huang YZ; Han B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1138-1142. PubMed ID: 37551489
[TBL] [Abstract][Full Text] [Related]
8. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group.
Hirokawa M; Sawada K; Fujishima N; Nakao S; Urabe A; Dan K; Fujisawa S; Yonemura Y; Kawano F; Omine M; Ozawa K;
Haematologica; 2008 Jan; 93(1):27-33. PubMed ID: 18166782
[TBL] [Abstract][Full Text] [Related]
9. Low- and intermediate-risk myelodysplastic syndrome with pure red cell aplasia.
Wang H; Niu H; Zhang T; Xing L; Shao Z; Fu R
Hematology; 2021 Dec; 26(1):444-446. PubMed ID: 34153199
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and outcomes of 11 patients with pure red cell aplasia at a single institution over a 13-year period.
Kawano N; Nagahiro Y; Yoshida S; Yamashita K; Himeji D; Yokota-Ikeda N; Uezono S; Shimao Y; Makino S; Shimoda K; Ueda A
Intern Med; 2013; 52(18):2025-30. PubMed ID: 24042508
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine restores hematopoietic function by compensating for decreased Tregs in patients with pure red cell aplasia and acquired aplastic anemia.
Dao AT; Yamazaki H; Takamatsu H; Sugimori C; Katagiri T; Maruyama H; Zaimoku Y; Maruyama K; Ly TQ; Espinoza L; Nakao S
Ann Hematol; 2016 Apr; 95(5):771-81. PubMed ID: 26968551
[TBL] [Abstract][Full Text] [Related]
12. Induced complete remission faster in adult patients with acquired pure red cell aplasia by combining cyclosporine A with corticosteroids.
Wu X; Yang Y; Lu X; Yin H; Wang S; Wang S; Hong M; Zhu Y; Lu R; Qiao C; Wu Y; He G; Li J
Medicine (Baltimore); 2019 Oct; 98(41):e17425. PubMed ID: 31593095
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and limitations of sirolimus conversion in liver transplant patients who develop renal dysfunction on calcineurin inhibitors.
Lam P; Yoshida A; Brown K; Abouljoud M; Bajjoka I; Dagher F; Moonka DK
Dig Dis Sci; 2004 Jun; 49(6):1029-35. PubMed ID: 15309896
[TBL] [Abstract][Full Text] [Related]
14. Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes.
Go RS; Li CY; Tefferi A; Phyliky RL
Blood; 2001 Jul; 98(2):483-5. PubMed ID: 11435321
[TBL] [Abstract][Full Text] [Related]
15. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.
Fujishima N; Sawada K; Hirokawa M; Oshimi K; Sugimoto K; Matsuda A; Teramura M; Karasawa M; Arai A; Yonemura Y; Nakao S; Urabe A; Omine M; Ozawa K;
Haematologica; 2008 Oct; 93(10):1555-9. PubMed ID: 18641028
[TBL] [Abstract][Full Text] [Related]
16. Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment.
Pliszczynski J; Kahan BD
Transplant Proc; 2011 Dec; 43(10):3657-68. PubMed ID: 22172822
[TBL] [Abstract][Full Text] [Related]
17. Renal function improvement after conversion to proliferation signal inhibitors during long-term follow-up in heart transplant recipients.
Kaplinsky E; González-Costello J; Manito N; Roca J; Barbosa MJ; Nebot M; Salazar-Mendiguchia J; Berdejo J; Mañas P; Miralles A; Cequier A
Transplant Proc; 2012 Nov; 44(9):2564-6. PubMed ID: 23146455
[TBL] [Abstract][Full Text] [Related]
18. Pure red cell aplasia associated with autoimmune hepatitis successfully treated with cyclosporine A.
Sato A; Sano F; Ishii T; Adachi K; Negishi R; Matsumoto N; Okuse C
Clin J Gastroenterol; 2014 Feb; 7(1):74-8. PubMed ID: 24523831
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group.
Hirokawa M; Sawada K; Fujishima N; Teramura M; Bessho M; Dan K; Tsurumi H; Nakao S; Urabe A; Fujisawa S; Yonemura Y; Kawano F; Oshimi K; Sugimoto K; Matsuda A; Karasawa M; Arai A; Komatsu N; Harigae H; Omine M; Ozawa K; Kurokawa M;
Br J Haematol; 2015 Jun; 169(6):879-86. PubMed ID: 25807974
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
